Trials / Completed
CompletedNCT04903496
Clinical Characteristics and Disease Burden of Diabetic Patients Based on Tianjin Regional Database
Characteristics, Treatment, and Economic Burden of Disease of Chinese Diabetic/Non-diabetic Patients With/Without Established Cardiovascular Disease, Chronic Kidney Disease, or at High Cardiovascular Risk
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,233,162 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to investigate the clinical characteristics, treatment, and economic burden of disease of Chinese diabetic/non-diabetic patients with/without established cardiovascular disease (CVD), chronic kidney disease (CKD), or at high cardiovascular risk, including: * Primary objectives: describe the proportion of Chinese diabetic/non-diabetic patients with established cardiovascular disease, CKD, or at high cardiovascular risk including hypertension and hyperlipidemia * Secondary objectives: describe the demographic characteristics of the last visit for all patients, and the demographic characteristics of inpatients over time; investigate the clinical characteristic for all patients
Conditions
Timeline
- Start date
- 2021-09-06
- Primary completion
- 2022-06-24
- Completion
- 2022-06-24
- First posted
- 2021-05-26
- Last updated
- 2024-11-12
- Results posted
- 2024-11-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04903496. Inclusion in this directory is not an endorsement.